OSTM1 and osteopetrosis: Mutations in OSTM1 (transmembrane protein 1associated with osteopetrosis) account for about 5 % ofARO cases and invariably cause osteopetrosis and severeprimary neurodegeneration with a life expectancy of lessthan two years.